Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.19B |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.94B |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$775M |
| 2 |
AbbVie
ABBV
|
+$540M |
| 3 |
Delta Air Lines
DAL
|
+$434M |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.89% |
| 2 | Healthcare | 2.92% |
| 3 | Financials | 2.71% |
| 4 | Consumer Discretionary | 2.52% |
| 5 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Kroger
KR
$34.7B
| $9.26M | ﹤0.01% |
148,130
-30,138
| -17% | -$1.97M |
|
|
VG
3327
Venture Global Inc
VG
$30.9B
| $9.25M | ﹤0.01% |
1,356,250
-104,218
| -7% | -$868K |
|
3328
CALL
Blackstone Secured Lending
BXSL
$5.43B
| $9.24M | ﹤0.01% |
351,000
+330,400
| +1,604% | +$8.87M |
|
3329
JPMorgan Short Duration Core Plus ETF
JSCP
$1.71B
| $9.23M | ﹤0.01% |
194,180
+166,376
| +598% | +$7.92M |
|
3330
Manhattan Associates
MANH
$11.2B
| $9.23M | ﹤0.01% |
53,273
-799,135
| -94% | -$146M |
|
3331
ASP Isotopes
ASPI
$510M
| $9.23M | ﹤0.01% |
1,725,553
+559,788
| +48% | +$4.45M |
|
3332
PUT
Akamai
AKAM
$17.8B
| $9.23M | ﹤0.01% |
105,800
-126,700
| -54% | -$10.4M |
|
3333
CALL
American Superconductor
AMSC
$1.6B
| $9.23M | ﹤0.01% |
320,600
+160,000
| +100% | +$6.92M |
|
3334
Tidewater
TDW
$3.85B
| $9.23M | ﹤0.01% |
182,669
+75,397
| +70% | +$3.98M |
|
3335
ArriVent BioPharma
AVBP
$1.43B
| $9.23M | ﹤0.01% |
+458,502
| New | +$9.54M |
|
3336
PUT
Trane Technologies
TT
$106B
| $9.22M | ﹤0.01% |
23,700
+5,100
| +27% | +$2.11M |
|
3337
CALL
Invesco DB US Dollar Index Bullish Fund
UUP
$423M
| $9.22M | ﹤0.01% |
341,200
-76,800
| -18% | -$2.14M |
|
3338
CALL
Darling Ingredients
DAR
$9.19B
| $9.22M | ﹤0.01% |
256,000
+113,800
| +80% | +$3.85M |
|
3339
Kimbell Royalty Partners
KRP
$1.42B
| $9.21M | ﹤0.01% |
783,301
+92,796
| +13% | +$1.19M |
|
3340
PUT
HF Sinclair
DINO
$14.8B
| $9.21M | ﹤0.01% |
199,900
-14,300
| -7% | -$737K |
|
3341
CALL
Weyerhaeuser
WY
$18.6B
| $9.19M | ﹤0.01% |
388,100
+208,400
| +116% | +$4.82M |
|
3342
Brown-Forman Class B
BF.B
$13B
| $9.19M | ﹤0.01% |
352,681
-1,362,220
| -79% | -$38.3M |
|
3343
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.31B
| $9.19M | ﹤0.01% |
190,994
-220,432
| -54% | -$10.6M |
|
|
AMTM
3344
CALL
Amentum Holdings
AMTM
$5.72B
| $9.18M | ﹤0.01% |
316,724
+212,150
| +203% | +$5.42M |
|
3345
EXL Service
EXLS
$5.11B
| $9.18M | ﹤0.01% |
216,233
+17,727
| +9% | +$725K |
|
3346
Evolus
EOLS
$407M
| $9.17M | ﹤0.01% |
1,379,131
+790,722
| +134% | +$5.36M |
|
3347
Dropbox
DBX
$8.17B
| $9.16M | ﹤0.01% |
329,603
-691,249
| -68% | -$20.1M |
|
3348
Vermilion Energy
VET
$1.61B
| $9.15M | ﹤0.01% |
1,097,383
+761,380
| +227% | +$6.29M |
|
3349
Essex Property Trust
ESS
$18.5B
| $9.15M | ﹤0.01% |
34,953
+21,665
| +163% | +$5.61M |
|
|
SLNO
3350
PUT
DELISTED
Soleno Therapeutics
SLNO
| $9.14M | ﹤0.01% |
197,500
+107,700
| +120% | +$5.91M |
|
Similar funds
Citadel Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Citadel Advisors held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,363 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
- Citadel Advisors added most to Amazon in Q4 2025, an estimated $2.49B increase.
- Citadel Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
- Citadel Advisors fully exited WEX in Q4 2025, selling an estimated $131M.
- Citadel Advisors's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
- Citadel Advisors opened 2,078 new positions and closed 2,191 in Q4 2025.
- Citadel Advisors's portfolio value rose 1.3% quarter-over-quarter to $666B.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.